Rigel Pharmaceuticals
RIGL
#6833
Rank
S$0.93 B
Marketcap
S$50.74
Share price
-0.91%
Change (1 day)
102.57%
Change (1 year)

Rigel Pharmaceuticals (RIGL) - Total assets

Total assets on the balance sheet as of March 2026 : S$0.65 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's total assets are S$0.65 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Rigel Pharmaceuticals - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31S$0.65 B195.85%
2024-12-31S$0.22 B43.97%
2023-12-31S$0.15 B-14%
2022-12-31S$0.18 B-20.42%
2021-12-31S$0.22 B54.92%
2020-12-31S$0.14 B-26.6%
2019-12-31S$0.19 B4.69%
2018-12-31S$0.19 B19.29%
2017-12-31S$0.15 B40.88%
2016-12-31S$0.11 B-39.32%
2015-12-31S$0.18 B-8.5%
2014-12-31S$0.20 B-28.89%
2013-12-31S$0.28 B-24.46%
2012-12-31S$0.37 B13.87%
2011-12-31S$0.33 B38.46%
2010-12-31S$0.24 B21.71%
2009-12-31S$0.19 B-3.96%
2008-12-31S$0.20 B23.47%
2007-12-31S$0.16 B-4.04%
2006-12-31S$0.17 B-29.38%
2005-12-31S$0.24 B91.2%
2004-12-31S$0.12 B36.31%
2003-12-31S$94.33 M22.61%
2002-12-31S$76.94 M-10.52%
2001-12-31S$85.98 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
S$119.39 B 18,231.85%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$147.16 B 22,494.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
S$77.39 M-88.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA